CAS 2245072-21-1

LIT-001

CAS: 2245072-21-1

LIT-001 improves social interaction in a mouse model of autism.It is the first nonpeptide oxytocin receptor agonist with EC50 of 55 nM and Ki of 226 nM.

Formula: C₃₀H₃₄F₃N₇O₄S

Purity: 97.67% - 98.25%

Color and Shape: Solid

Molecular weight: 645.7

Ref: TM-T11857

(S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine-5-carbonyl)benzyl)pyrrolidine-1-carboxamide, Trifluoroacetate

CAS: 2245072-21-1

Formula: C₃₀H₃₄F₃N₇O₄S

Purity: 98%

Molecular weight: 645.6957

Ref: IN-DA01V2NM

LIT-001

CAS: 2245072-21-1

LIT-001

Purity: ≥95%

Molecular weight: 645.7g/mol

Ref: 54-BUP09501

LIT-001

CAS: 2245072-21-1

LIT-001 is a lithium-based experimental therapeutic agent, which is synthesized through advanced chemical processes involving lithium isotopes and organic ligands. Its mode of action involves the modulation of intracellular signaling pathways, particularly affecting the phosphoinositide cycle and glycogen synthase kinase-3 (GSK-3) inhibition. This modulation results in neuroprotective, mood-stabilizing, and anti-inflammatory effects.

Formula: C₃₀H₃₄F₃N₇O₄S

Purity: Min. 95%

Molecular weight: 645.7 g/mol

Ref: 3D-VPD07221